Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ZVRA
#2506
Zevra Therapeutics, Inc. Common Stock
8.930
0
+0.68%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+0.68%
Monatliche Änderung
0.00%
6 month change
-16.07%
Jahresänderung
-16.07%
Vorheriger Schlusskurs
8.870
0
Open
8.930
0
Bid
Ask
Low
8.930
0
High
8.930
0
Volumen
101
Märkte
Aktien
Gesundheitswesen
ZVRA
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
53.38 M
54.12 M
54.68 M
56.14 M
56.3 M
—
Valuation ratios
Enterprise value
316.39 M
417.54 M
372.21 M
446.84 M
480.95 M
1.72 B
Price to earnings ratio
3.26
3.66
3.74
3.22
4.68
15.31
Price to sales ratio
11.02
16.34
9.11
7.49
6.08
39.01
Price to cash flow ratio
4.14
5.54
5.59
9.31
19.69
40.12
Price to book ratio
1.35
9.72
1.95
1.71
1.56
14.94
Enterprise value to EBITDA ratio
-3.65
-4.81
-4.89
16.85
8.25
15.41
Profitability ratios
Return on assets %
0.17
0.2
0.02
0.29
0
0.51
Return on equity %
0.48
0.9
0.08
0.64
0
1.62
Return on invested capital %
111.66
15.33
8.18
385.46
17.92
426.9
Gross margin %
-4.14
75.38
85.49
52.2
95.26
308.33
Operating margin %
739
127.28
26.28
274.28
15.87
443.72
EBITDA margin %
-736.16
-164.36
-26.13
304.84
17.51
131.87
Net margin %
899.19
295.07
15.19
288.44
2.08
600.79
Liquidity ratios
Quick ratio
2.63
2.14
2.93
7.81
8.57
21.45
Current ratio
2.88
2.53
3.02
7.85
8.62
22.02
Inventory turnover
0.41
0.27
0.38
6.75
1
8.41
Asset turnover
0.02
0.07
0.12
0.12
0.1
0.4
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.31
0.33
0.35
0.24
0.23
1.15
Long term debt to total equity ratio
0.84
1.5
1.46
0.52
0.46
3.94
Per share metrics
Operating cash flow per share
0.38
0.35
0.15
0.06
-0.08
0.48
EBIT per share
-0.6
-0.47
-0.13
1.37
0.07
0.85
EBITDA per share
-0.57
-0.43
-0.1
1.4
0.08
0.95
Total debt per share
—
—
—
—
—
—
Cash per share
1.87
1.5
1.16
3.6
3.57
9.82
Net current asset value per share
2.08
1.86
1.51
4.02
4.02
11.41
Tangible book value per share
-0.12
-0.74
-0.57
1.87
2.18
2.74
Working capital per share
1.36
1.12
1.01
3.51
3.56
9.2
Book value per share
1.46
0.86
0.76
2.08
2.38
6.08
Nachrichten
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates
Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates
CEO von Zevra Therapeutics verkauft Aktien im Wert von 125.000 $
Neil F. McFarlane, Zevra Therapeutics president, sells $125k in shares
Zevra Therapeutics: CMO Quartel veräußert Aktien im Wert von 40.000 US-Dollar/n
Zevra Therapeutics: CCO Schafer veräußert Aktienpaket im Wert von 29.800 US-Dollar
Zevra Therapeutics CMO Quartel sells $40k in shares
Schafer Joshua, CCO of Zevra, sells $29,800 in ZVRA stock
CEO von Zevra Therapeutics veräußert Aktien im Wert von 853.000 $
Zevra Therapeutics CEO McFarlane sells $853k in shares
Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Zevra Stock: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market (ZVRA)